Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Invested Capital (2020 - 2025)

HCW Biologics (HCWB) has disclosed Invested Capital for 6 consecutive years, with -$2.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Invested Capital rose 39.91% year-over-year to -$2.1 million, compared with a TTM value of -$2.1 million through Sep 2025, up 39.91%, and an annual FY2024 reading of $607693.0, down 96.93% over the prior year.
  • Invested Capital was -$2.1 million for Q3 2025 at HCW Biologics, down from $315179.0 in the prior quarter.
  • Across five years, Invested Capital topped out at $54.0 million in Q3 2021 and bottomed at -$23.2 million in Q2 2021.
  • Average Invested Capital over 5 years is $20.5 million, with a median of $19.8 million recorded in 2023.
  • The sharpest move saw Invested Capital soared 406.21% in 2021, then plummeted 111.61% in 2024.
  • Year by year, Invested Capital stood at $51.2 million in 2021, then fell by 14.37% to $43.8 million in 2022, then tumbled by 54.91% to $19.8 million in 2023, then plummeted by 96.93% to $607693.0 in 2024, then tumbled by 446.75% to -$2.1 million in 2025.
  • Business Quant data shows Invested Capital for HCWB at -$2.1 million in Q3 2025, $315179.0 in Q2 2025, and -$856684.0 in Q1 2025.